JPWO2021096270A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021096270A5 JPWO2021096270A5 JP2022528544A JP2022528544A JPWO2021096270A5 JP WO2021096270 A5 JPWO2021096270 A5 JP WO2021096270A5 JP 2022528544 A JP2022528544 A JP 2022528544A JP 2022528544 A JP2022528544 A JP 2022528544A JP WO2021096270 A5 JPWO2021096270 A5 JP WO2021096270A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical compositions
- multiple sclerosis
- treating multiple
- smes
- korea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000006417 multiple sclerosis Diseases 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 102100036009 5'-AMP-activated protein kinase catalytic subunit alpha-2 Human genes 0.000 description 1
- 101000783681 Homo sapiens 5'-AMP-activated protein kinase catalytic subunit alpha-2 Proteins 0.000 description 1
- 230000007987 cellular zinc ion homeostasis Effects 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2019-0145709 | 2019-11-14 | ||
| KR20190145709 | 2019-11-14 | ||
| PCT/KR2020/015932 WO2021096270A1 (ko) | 2019-11-14 | 2020-11-12 | Ampk 억제기능과 아연항상성 조절기능에 기반한 다발성 경화증 치료용 약학적 조성물 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023501814A JP2023501814A (ja) | 2023-01-19 |
| JP2023501814A5 JP2023501814A5 (https=) | 2023-04-25 |
| JPWO2021096270A5 true JPWO2021096270A5 (https=) | 2023-04-25 |
| JP7398840B2 JP7398840B2 (ja) | 2023-12-15 |
Family
ID=75911395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022528544A Active JP7398840B2 (ja) | 2019-11-14 | 2020-11-12 | Ａｍｐｋ抑制機能と亜鉛恒常性調節機能に基づく多発性硬化症治療用の薬学的組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12343335B2 (https=) |
| EP (1) | EP4066832A4 (https=) |
| JP (1) | JP7398840B2 (https=) |
| KR (1) | KR102770734B1 (https=) |
| CN (1) | CN114929217A (https=) |
| WO (1) | WO2021096270A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4255419A (en) * | 1979-09-27 | 1981-03-10 | Allergan Pharmaceuticals, Inc. | Zinc deficiency in multiple sclerosis |
| JP2006513143A (ja) | 2002-08-29 | 2006-04-20 | アプライド リサーチ システムズ アルス ホールディング ナムローゼ フエンノートシャップ | タンパク質チロシンホスファターゼ阻害剤 |
| GB0915892D0 (en) * | 2009-09-10 | 2009-10-14 | Smithkline Beecham Corp | Compounds |
| KR101324647B1 (ko) | 2010-12-10 | 2013-11-01 | 한국과학기술연구원 | 다발성신경경화증의 치료 또는 예방용 조성물 및 이의 스크리닝 방법 |
| EP2651405A2 (en) | 2010-12-14 | 2013-10-23 | Electrophoretics Limited | Casein kinase 1 (ck1 ) inhibitors |
| EP2685976B1 (en) * | 2011-03-17 | 2017-12-27 | Tel HaShomer Medical Research Infrastructure and Services Ltd. | Quinolone analogs for treating autoimmune diseases |
| CN104059060B (zh) | 2014-05-30 | 2017-08-01 | 西安交通大学 | 一种5‑(1h‑吲哚‑3‑亚甲基)‑1,3‑噻唑烷‑4‑酮类衍生物及其合成方法和应用 |
| KR101911785B1 (ko) | 2016-08-09 | 2018-10-26 | 세종대학교 산학협력단 | Ampk 억제기능에 기반한 뇌졸중 치료용 약학적 조성물 |
-
2020
- 2020-11-12 US US17/776,693 patent/US12343335B2/en active Active
- 2020-11-12 WO PCT/KR2020/015932 patent/WO2021096270A1/ko not_active Ceased
- 2020-11-12 EP EP20887409.9A patent/EP4066832A4/en not_active Withdrawn
- 2020-11-12 CN CN202080093043.2A patent/CN114929217A/zh active Pending
- 2020-11-12 KR KR1020227017186A patent/KR102770734B1/ko active Active
- 2020-11-12 JP JP2022528544A patent/JP7398840B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SA522440778B1 (ar) | Rip1k مثبطات | |
| SA522431867B1 (ar) | مثبطات كيناز بروتين-1 المتفاعل مع المستقبل غير متجانسة الحلقات | |
| JOP20200278A1 (ar) | مركبات تثبيط rip1 وطرق لتحضير واستخدامها | |
| JOP20210290A1 (ar) | مشتقات حمض إيتاكونيك واستخداماتها في علاج مرض التهابي أو مرض مصاحب لاستجابة مناعية غير مرغوب فيها | |
| BR112021022624A2 (pt) | Compostos para o tratamento da doença de huntington | |
| EP4674481A3 (en) | Cd73 inhibitors | |
| CN111655682A (zh) | 一种高活性sting蛋白激动剂化合物 | |
| CN110121502A (zh) | 一种抗抑郁化合物及其制备方法和应用 | |
| JP2017155062A5 (https=) | ||
| PH12021551070A1 (en) | Pharmaceutical composition comprising histone deacetylase 6 inhibitors | |
| EA202192925A1 (ru) | Твердые формы ингибитора glyt1 | |
| CN111295380A (zh) | 一种高活性csf1r抑制剂化合物 | |
| EA201992739A1 (ru) | Композиции для обработки поврежденных волос | |
| KR102239075B9 (ko) | IF1 (ATPase inhibitory factor 1)을 유효성분으로 함유하는 근감소증의 예방 또는 치료용 약학 조성물 | |
| Pervaiz et al. | Riproximin: A type II ribosome inactivating protein with anti-neoplastic potential induces IL24/MDA-7 and GADD genes in colorectal cancer cell lines | |
| JP2021190215A5 (https=) | ||
| Chauhan et al. | Phloretin protects macrophages from E. coli-induced inflammation through the TLR4 signaling pathway | |
| CY1125444T1 (el) | Συνθεσεις εναντι μολυνσεων καντιντιασης | |
| CN111868060A (zh) | 二氢吡啶并酞嗪酮衍生物、其制备方法及应用 | |
| JPWO2021096270A5 (https=) | ||
| WO2018231058A3 (en) | ANTIMICROBIAL PEPTIDES AND THEIR MIXTURES HAVING ANTIMICROBIAL ACTIVITY AGAINST NEGATIVE GRAM PATHOGENS | |
| MX2021006138A (es) | Otros compuestos heteroaromaticos que tienen actividad contra el vrs. | |
| WO2019155360A3 (en) | Pharmaceutical composition for treating bacterial and viral infections | |
| GEAP202416568A (en) | Triazolone derivative salt as neutrophil elastase inhibitor | |
| Puerta-Guardo | From pathogenic infections to inflammation and disease-the tumultuous road of the ‘cytokine storm’ |